As genomic data begins to inform more aspects of patient care, new products, AI and the cloud offer to simplify the storage and use of DNA information. Precision medicine initiatives are taking hold at healthcare organizations as providers begin to incorporate genetic and molecular data into treatment decisions for patients. In fact, according to Trends in Precision Medicine Adoption by Oracle, 62 percent of healthcare organizations surveyed participate in research activities to drive biomarker discovery or translational research. Another 12 percent have plans to participate in precision medicine studies in the next two years.

Source: Click here

Share this article

Facebook Comments